The QRNA brand, founded in 2014 (Netherlands), from 1 sister brand and 2214 competing brands. The QRNA brand is owned by ProQR Therapeutics, a company listed in New York. The International Securities Identification Number (ISIN) of ProQR Therapeutics is NL0010872495. The sector of QRNA is Biotechnology.

QRNA is a brand of ProQR Therapeutics (PRQR) Share price

International deposit : 2014 Business sector Biotechnology

Share price and profitability of the share ProQR Therapeutics (QRNA)

Buy ProQR Therapeutics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 2.08

Portfolio valuation
ProQR Therapeutics (QRNA) over 5 years* USD 0.39

Stock market history ProQR Therapeutics (QRNA)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
ProQR Therapeutics

See more brands of ProQR Therapeutics

Rival brands
QRNA

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS